Literature DB >> 16769352

Prader-Willi syndrome-associated obesity treated by biliopancreatic diversion with duodenal switch. Case report and literature review.

Spiros T Papavramidis1, Efstathios V Kotidis, Orestis Gamvros.   

Abstract

BACKGROUND: Prader-Willi syndrome (PWS) is a congenital chromosomal disorder characterized by compulsive hyperphagia and the early development of obesity. Obesity is identified as the main cause of morbidity and mortality in PWS individuals. Thus, body weight reduction is of major importance for a prolonged survival. PATIENT-
METHOD: A 20-year-old female patient with PWS was referred to our department for surgical treatment of her obesity. At admission, her body weight was 153 kg, and her body mass index (BMI) was 74.33 kg/m(2). The patient underwent biliopancreatic diversion with duodenal switch, as well as cholecystectomy and appendicectomy. The volume of the gastric remnant was 100 mL, and the lengths of the gastric and common limbs were 250 and 60 cm, respectively.
RESULTS: Eighteen months after the operation, the patient lost 63 kg with no considerable changes in her eating habits. Her sleep disturbances and sleep apnea disappeared, and her social life dramatically improved.
CONCLUSIONS: Biliopancreatic diversion with duodenal switch seems to be a good method for the treatment of PWS-associated obesity because it offers good results in weight loss without the need for revision, good quality of life, and a chance for a prolonged survival.

Entities:  

Mesh:

Year:  2006        PMID: 16769352     DOI: 10.1016/j.jpedsurg.2006.01.065

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

Review 1.  A review of unmet needs in obesity management.

Authors:  N Nguyen; J K Champion; J Ponce; B Quebbemann; E Patterson; B Pham; W Raum; J N Buchwald; G Segato; F Favretti
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

Review 2.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

3.  Long-term experience with duodenal switch in adolescents.

Authors:  Picard Marceau; Simon Marceau; Simon Biron; Frederic-Simon Hould; Stefane Lebel; Odette Lescelleur; Laurent Biertho; John G Kral
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

4.  Patients with Prader-Willi Syndrome (PWS) Underwent Bariatric Surgery Benefit more from High-Intensity Home Care.

Authors:  Songhao Hu; Biao Huang; Ken Loi; Xiaomei Chen; Qinyu Ding; Lan Luo; Cunchuan Wang; Wah Yang
Journal:  Obes Surg       Date:  2022-03-15       Impact factor: 3.479

Review 5.  Critical analysis of bariatric procedures in Prader-Willi syndrome.

Authors:  A O Scheimann; M G Butler; L Gourash; C Cuffari; W Klish
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-01       Impact factor: 2.839

6.  BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits.

Authors:  F De Peppo; G Di Giorgio; M Germani; E Ceriati; P Marchetti; C Galli; M G Ubertini; S Spera; G Ferrante; M Cuttini; M Cappa; G Castelli Gattinara; M Rivosecchi; A Crinò
Journal:  Obes Surg       Date:  2008-05-01       Impact factor: 4.129

7.  Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese.

Authors:  Anthony K W Fong; Simon K H Wong; Candice C H Lam; Enders K W Ng
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

8.  Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children.

Authors:  Chenhong Zhang; Aihua Yin; Hongde Li; Ruirui Wang; Guojun Wu; Jian Shen; Menghui Zhang; Linghua Wang; Yaping Hou; Haimei Ouyang; Yan Zhang; Yinan Zheng; Jicheng Wang; Xiaofei Lv; Yulan Wang; Feng Zhang; Benhua Zeng; Wenxia Li; Feiyan Yan; Yufeng Zhao; Xiaoyan Pang; Xiaojun Zhang; Huaqing Fu; Feng Chen; Naisi Zhao; Bruce R Hamaker; Laura C Bridgewater; David Weinkove; Karine Clement; Joel Dore; Elaine Holmes; Huasheng Xiao; Guoping Zhao; Shengli Yang; Peer Bork; Jeremy K Nicholson; Hong Wei; Huiru Tang; Xiaozhuang Zhang; Liping Zhao
Journal:  EBioMedicine       Date:  2015-07-10       Impact factor: 8.143

Review 9.  GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Authors:  Cheri L Deal; Michèle Tony; Charlotte Höybye; David B Allen; Maïthé Tauber; Jens Sandahl Christiansen
Journal:  J Clin Endocrinol Metab       Date:  2013-03-29       Impact factor: 5.958

10.  Prader-willi syndrome: clinical aspects.

Authors:  Grechi Elena; Cammarata Bruna; Mariani Benedetta; Di Candia Stefania; Chiumello Giuseppe
Journal:  J Obes       Date:  2012-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.